Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/19810
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSrikanth, K-
dc.contributor.authorKumar, Ch. Anil-
dc.contributor.authorGoswami, Diptendu-
dc.contributor.authorDe, A U-
dc.contributor.authorJha, Tarun-
dc.date.accessioned2013-07-16T06:36:47Z-
dc.date.available2013-07-16T06:36:47Z-
dc.date.issued2001-04-
dc.identifier.issn0975-0959 (Online); 0301-1208 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/19810-
dc.description120-123en_US
dc.description.abstractAs a part of a composite programme of rational drug design (RDD)1, we had synthesized some substituted benzene sulphonyl glutamines and evaluated their inhibitory activities against Ehrlich Ascites Carcinoma (EAC) cell line in Swiss albino mice. Quantitative structure activity relationship (QSAR) studies of these inhibitory activities using Fujita-Ban model as well as Modified Hansch-Fujita model gave excellent correlations (correlation coefficient r = 0.89 and 0.82 respectively). These results could be useful in designing 'lead' compound with potent inhibitory activity on DNA and RNA synthesis and tumour development.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rightsCC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJBB Vol.38(1-2) [February-April 2001]en_US
dc.titleQuantitative structure activity relationship (QSAR) studies of some substituted benzenesulphonyl glutamines as tumour suppressorsen_US
dc.typeArticleen_US
Appears in Collections:IJBB Vol.38(1-2) [February-April 2001]

Files in This Item:
File Description SizeFormat 
IJBB 38(1-2) 120-123.pdf699.38 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.